GPT Healthcare (GPTHEALTH) | Financial Analysis & Statements
GPT Healthcare Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.1B
Gross Profit
660.2M
61.63%
Operating Income
111.8M
10.44%
Net Income
76.8M
7.17%
EPS (Diluted)
₹0.94
Balance Sheet Metrics
Total Assets
3.8B
Total Liabilities
1.4B
Shareholders Equity
2.5B
Debt to Equity
0.55
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
GPT Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.1B | 4.0B | 3.6B | 3.4B | 2.4B |
| Cost of Goods Sold | 1.5B | 1.5B | 1.3B | 1.4B | 989.3M |
| Gross Profit | 2.6B | 2.5B | 2.3B | 2.0B | 1.4B |
| Gross Margin % | 63.8% | 63.1% | 62.9% | 58.1% | 59.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 121.2M | 72.8M | 80.0M | 43.6M | 60.4M |
| Other Operating Expenses | 480.7M | 449.2M | 435.6M | 402.7M | 344.8M |
| Total Operating Expenses | 601.9M | 522.0M | 515.6M | 446.4M | 405.2M |
| Operating Income | 671.2M | 720.6M | 594.4M | 605.2M | 377.9M |
| Operating Margin % | 16.5% | 18.0% | 16.5% | 18.0% | 15.6% |
| Non-Operating Items | |||||
| Interest Income | 46.2M | 36.0M | 38.8M | 39.7M | 39.4M |
| Interest Expense | 25.3M | 64.9M | 84.4M | 101.9M | 127.6M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 693.5M | 680.4M | 559.7M | 540.8M | 288.8M |
| Income Tax | 194.2M | 202.7M | 169.6M | 124.2M | 77.9M |
| Effective Tax Rate % | 28.0% | 29.8% | 30.3% | 23.0% | 27.0% |
| Net Income | 499.2M | 477.7M | 390.1M | 416.6M | 210.9M |
| Net Margin % | 12.3% | 12.0% | 10.8% | 12.4% | 8.7% |
| Key Metrics | |||||
| EBITDA | 927.1M | 940.5M | 786.9M | 777.4M | 547.4M |
| EPS (Basic) | ₹6.08 | ₹5.96 | ₹4.87 | ₹5.08 | ₹2.57 |
| EPS (Diluted) | ₹6.08 | ₹5.96 | ₹4.75 | ₹5.08 | ₹2.57 |
| Basic Shares Outstanding | 82054823 | 80098187 | 82054823 | 82054823 | 82054823 |
| Diluted Shares Outstanding | 82054823 | 80098187 | 82054823 | 82054823 | 82054823 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
GPT Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 16.6M | 16.9M | 66.0M | 82.7M | 47.8M |
| Short-term Investments | 319.8M | 173.4M | 102.8M | 53.9M | - |
| Accounts Receivable | 197.0M | 242.8M | 206.8M | 134.3M | 172.6M |
| Inventory | 88.2M | 81.5M | 89.2M | 72.8M | 64.3M |
| Other Current Assets | 22.7M | 15.6M | - | - | - |
| Total Current Assets | 788.2M | 801.6M | 812.7M | 856.9M | 863.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.3B | 38.0K | 38.0K | 40.0K | 40.0K |
| Goodwill | 9.9M | 8.5M | 3.9M | 460.0K | 810.0K |
| Intangible Assets | 9.9M | 8.5M | 3.9M | 460.0K | 810.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 40.5M | 6.7M | - | - | - |
| Total Non-Current Assets | 3.1B | 2.7B | 2.5B | 2.4B | 2.3B |
| Total Assets | 3.8B | 3.5B | 3.3B | 3.2B | 3.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 347.6M | 373.9M | 333.9M | 289.3M | 258.9M |
| Short-term Debt | 125.7M | 115.7M | 256.0M | 241.3M | 212.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.7M | 967.0K | 767.0K | 420.0K | 470.0K |
| Total Current Liabilities | 742.4M | 772.1M | 818.4M | 684.8M | 600.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 227.3M | 189.7M | 567.5M | 774.2M | 1.0B |
| Deferred Tax Liabilities | 192.8M | 119.6M | 35.7M | 0 | 0 |
| Other Non-Current Liabilities | 107.0M | 113.4M | - | - | - |
| Total Non-Current Liabilities | 621.6M | 498.2M | 795.5M | 965.7M | 1.2B |
| Total Liabilities | 1.4B | 1.3B | 1.6B | 1.7B | 1.8B |
| Equity | |||||
| Common Stock | 820.5M | 820.5M | 799.0M | 799.0M | 179.4M |
| Retained Earnings | 887.5M | 593.9M | 437.8M | 366.0M | 123.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.5B | 2.2B | 1.7B | 1.6B | 1.3B |
| Key Metrics | |||||
| Total Debt | 353.0M | 305.4M | 823.6M | 1.0B | 1.3B |
| Working Capital | 45.7M | 29.5M | -5.8M | 172.1M | 263.3M |
Balance Sheet Composition
GPT Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 693.5M | 680.4M | 559.7M | 540.8M | 288.8M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -25.1M | -130.0M | -45.4M | -700.0K | -44.9M |
| Operating Cash Flow | 631.6M | 569.9M | 553.1M | 601.8M | 324.7M |
| Investing Activities | |||||
| Capital Expenditures | -494.4M | -192.2M | -84.9M | -103.9M | -61.2M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -191.0M | -360.7M | -100.0M | -342.0M | -110.0K |
| Investment Sales | 198.4M | 141.5M | 54.4M | 243.9M | 0 |
| Investing Cash Flow | -487.0M | -411.4M | -130.5M | -202.0M | -61.3M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -287.2M | -239.7M | -319.6M | -172.6M | -134.4M |
| Debt Issuance | 94.0M | 0 | 2.4M | 0 | 184.2M |
| Debt Repayment | -87.5M | -527.7M | -300.3M | -288.8M | -100.5M |
| Financing Cash Flow | -278.6M | -365.9M | -630.9M | -447.4M | -73.9M |
| Free Cash Flow | 174.7M | 494.3M | 564.1M | 554.2M | 369.5M |
| Net Change in Cash | -134.0M | -207.4M | -208.3M | -47.6M | 189.4M |
Cash Flow Trend
GPT Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
27.54
Forward P/E
17.67
Price to Book
4.41
Price to Sales
2.49
PEG Ratio
-1.17
Profitability Ratios
Profit Margin
9.06%
Operating Margin
11.32%
Return on Equity
20.14%
Return on Assets
12.99%
Financial Health
Current Ratio
1.03
Debt to Equity
38.28
Beta
0.08
Per Share Data
EPS (TTM)
₹4.94
Book Value per Share
₹30.88
Revenue per Share
₹54.57
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GPTHEALTH | 11.0B | 27.54 | 4.41 | 20.14% | 9.06% | 38.28 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Indraprastha Medical | 37.3B | 20.08 | 5.57 | 26.98% | 12.60% | 4.76 |
| Dr. Agarwal's Eye | 24.3B | 34.01 | 7.52 | 26.07% | 15.50% | 106.45 |
| Shalby | 16.7B | 207.28 | 1.75 | 0.63% | 0.72% | 53.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.





